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Abstract
Background: The Pseudomonas aeruginosa MexEF-OprN efflux pump confers resistance to clinically significant antibiotics.
Regulation of mexEF-oprN operon expression is multifaceted with the MexT activator being one of the most prominent
regulatory proteins.
Methodology: We have exploited the impaired metabolic fitness of a P. aeruginosa mutant strain lacking several efflux
pump of the resistance nodulation cell division superfamily and the TolC homolog OpmH, and isolated derivatives (large
colony variants) that regained fitness by incubation on nutrient-rich medium in the absence of antibiotics. Although the
mexEF-oprN operon is uninducible in this mutant due to a 8-bp mexT insertion present in some P. aeruginosa PAO1 strains,
the large colony variants expressed high levels of MexEF-OprN. Unlike large colony variants obtained after plating on
antibiotic containing medium which expressed mexEF-oprN in a MexT-dependent fashion as evidenced by clean excision of
the 8-bp insertion from mexT, mexEF-oprN expression was MexT-independent in the large colony variants obtained by
plating on LB alone since the mexT gene remained inactivated. A search for possible regulators of mexEF-oprN expression
using transposon mutagenesis and genomic library expression approaches yielded several candidates but proved
inconclusive.
Significance: Our results show that antibiotic and metabolic stress lead to up-regulation of MexEF-OprN expression via
different mechanisms and that MexEF-OprN does not only extrude antimicrobials but rather serves other important
metabolic functions.
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Introduction
Pseudomonas aeruginosa is a non-fermentative Gram-negative
nosocomial pathogen of significant clinical relevance. It is known
to cause a variety of infections including pneumonia, bloodstream
infections, urinary tract infections, endocarditis, and burn wound
infections [1,2,3,4,5,6,7]. Infections caused by P. aeruginosa pose a
considerable challenge in the clinical settings owing to its high
intrinsic resistance to almost all antibiotics in clinical use [8,9,
10,11,12,13,14]. Energy-mediated efflux of antibiotics by Resis-
tance-Nodulation-Cell Division (RND) pumps in P. aeruginosa is
considered the major factor responsible for its high antibiotic
resistance. To date, 11 different RND pumps, capable of effluxing
antibiotics/antimicrobial products, have been characterized in P.
aeruginosa that include MexAB-OprM [15], MexCD-OprJ [16],
MexEF-OprN [17], MexGHI-OpmD [18], MexJK-OprM/
OpmH [19], MexMN [20], MexPQ-OpmE [20], MexVW-OprM
[21], MexXY-OprM [22], TriABC-OpmH [23], and MuxABC-
OpmB [24]. Expression of these pumps is usually under tight
regulatory control, however molecular mechanisms that regulate
the expression of a number of these pumps are not fully
understood. Elucidating the mechanisms of regulation of RND
pump will not only aid in a better understanding of the antibiotic
resistance of P. aeruginosa but will also provide valuable insights into
their natural function.
The MexEF-OprN pump is the only positively regulated RND
pump of P. aeruginosa and its expression is activated by a LysR
family protein, MexT, encoded by a gene located upstream of the
mexEF-oprN operon [25]. It has been shown to efflux fluoroquin-
olones, trimethoprim, and chloramphenicol [17,26]. MexEF-
OprN overexpression has also been shown to be associated with
a concurrent downregulation of the outermembrane protein
OprD, which in turn results in decreased susceptibility to
imipenem [17,27]. Interestingly, a number of isolates of P.
aeruginosa have been reported that contain a 8-bp insertion in the
mexT gene that results in an inactive MexT protein that is unable
to activate the expression of mexEF-oprN operon [28]. In addition,
the regulation of mexEF-oprN operon has been shown to be
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global regulator of virulence genes in P. aeruginosa, has also shown
to be able to repress the expression of the MexEF-OprN pump
[29]. In addition to resistance to antibiotics, the overexpression of
the MexEF-OprN pump was linked to reduced production of
extracellular virulence factors like pyocyanin, elastase, and
rhamnolipids [30]. Recent studies also link MexT with the
expression of the type III secretion system in P. aeruginosa [31].
MexEF-OprN overexpression has also been observed in response
to nitrosative stress in absence of any antibiotics [32,33]. These
studies indicate involvement of a complex mexEF-oprN regulatory
network which largely remains to be elucidated.
The present study was performed to advance our understanding
of the regulatory mechanisms involved in the expression of
MexEF-OprN. We show that, in the absence of other RND
pumps, the expression of MexEF-OprN pump can be activated in
a nutrient rich-medium in absence of an antibiotic stress
independent of the MexT protein. We also identify putative novel
proteins that could be involved in the regulation of this RND
pump.
Results
A P. aeruginosa multiple efflux pump-deficient mutant
regains fitness by overexpressing MexEF-OprN
P. aeruginosa PAO386 (Table 1) was used for our studies. This
strain contains deletions in four different RND pump encoding
operons, namely mexAB-oprM, mexCD-oprJ, mexJK, and mexXY.I n
addition, it also lacks the structural gene for the outer membrane
protein OpmH, the P. aeruginosa TolC homolog. The MexEF-
OprN pump is not expressed in PAO386 as a result of an 8-bp
insertion in the mexT gene. This strain exhibits a slow growing
phenotype and the colonies on LB agar (without supplementation
of any antibiotics) have a pin-point morphology after an overnight
incubation at 37uC. However, following an extended incubation
(5–7 days) at room temperature, a few large-colony variants (with
stable phenotype, for example unsectored) were observed (Fig. 1).
One such colony was isolated, designated PAO573, and retained
for further characterization.
To assess whether the increased fitness of PAO573 was due to
expression of an efflux pump, we assessed the antibiotic
susceptibility profile of this strain. PAO573 was highly resistant
to chloramphenicol (MIC .1024 mg/mL) and trimethoprim
(MIC .1024 mg/mL) when compared to PAO386 (in this strain
both chloramphenicol and trimethoprim MICs were 16 mg/mL).
Since both of these antibiotics are MexEF-OprN pump substrates
[17] we suspected possible expression of this efflux system in
PAO573.
To assess this notion, a ciprofloxacin resistant derivative was
isolated by plating PAO386 onto LB agar supplemented with
0.05 mg/mL of ciprofloxacin, a condition known to select for
MexEF-OprC expressing NfxC-type mutants. One colony grow-
ing after incubation at 37uC for 48 h was selected and the strain
designated as PAO393. This mutant was also highly resistant to
chloramphenicol and trimethoprim, exhibiting the same MIC
values as PAO573 (.1024 mg/mL).
Confirmation of MexEF-OprN expression in PAO393 and
PAO573
To confirm MexEF-OprN expression in PAO393 and PAO573,
we first performed Western blot analysis of whole cell lysates using
anti-OprN antibodies (Fig. 2). OprN could not be detected in the
Table 1. P. aeruginosa strains used in this study.
Strain Relevant characteristics Source/Reference
PAO1 P. aeruginosa prototroph. Contains the 8-bp insertion in the mexT gene, and thus the mexEF-oprN operon is uninducible. [46]
PAO327 PAO1 with D(mexAB-oprM) D(mexCD-oprJ) D(mexXY) [19]
PAO386 PAO1 with D(mexAB-oprM) D(mexCD-oprJ) D(mexJK) D(mexXY) DopmH. This study
PAO393 Cp
r mutant expressing mexEF-oprN derived from PAO386 plated on Cp-supplemented LB agar This study
PAO573 Large colony variant expressing mexEF-oprN derived from PAO386 plated on LB agar This study
PAO599 Gm
r; PAO386::mini-Tn7T-Gm-mexEp-lacZ This study
PAO600 Gm
r; PAO393::mini-Tn7T-Gm-mexEp-lacZ This study
PAO601 Gm
r; PAO573::mini-Tn7T-Gm-mexEp-lacZ This study
PAO602 Gm
r, PAO1::mini-Tn7T-Gm-mexEp-lacZ This study
PAO604 PAO1::mini-Tn7T-mexEp-lacZ; Gm-cassette deleted from PAO602 This study
PAO605 PAO386::mini-Tn7T-mexEp-lacZ; Gm-cassette deleted from PAO599. This study
PAO606 PAO393::mini-Tn7T-mexEp-lacZ; Gm-cassette deleted from PAO600 This study
PAO607 PAO573::mini-Tn7T-mexEp-lacZ; Gm-cassette deleted from PAO601 This study
PAO706 Gm
r; PAO327::mini-Tn7T-Gm-mexEp-lacZ This study
PAO707 PAO327::mini-Tn7T-mexEp-lacZ; Gm-cassette deleted from PAO706 This study
PAO709 Gm
r; PAO707 with DPA02050::Gm This study
PAO712 Gm
r; PAO707 with DPA0487::Gm This study
PAO719 PAO707 with DPA0487; Gm-cassette deleted from PAO712 This study
8485 Tc
r; mvaT::ISlacZ/hah (transposon insertion at nucleotide 57 relative to the start codon) UWGC
PAO1081 Gm
r; 8485::mini-Tn7T-Gm-lacZ This study
PAO1084 Gm
r, 8485::mini-Tn7T-Gm-mexEp-lacZ This study
Abbreviations: Cp, ciprofloxacin; Gm, gentamicin; mexEp, mexE promoter;
r, resistant; Tc, tetracycline; UWGC, University of Washington Genome Center.
doi:10.1371/journal.pone.0026520.t001
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and PAO573.
Confirmation of the overexpression of the mexEF-oprN operon in
the various mutant strains was also achieved by assessing mexEF-
oprN transcription using transcriptional mexEpromoter-lacZ fusions
integrated in single-copy into the chromosomes of the respec-
tive mutants. PAO604 (PAO1::mexEpromoter-lacZ) and PAO605
(PAO386::mexEpromoter-lacZ) did not show any significant b-
galactosidase activity (Fig. 3). In contrast, PAO606 (PAO393::mex-
Epromoter-lacZ) and PAO607 (PAO573:: mexEpromoter-lacZ) both
showed significant mexEpromoter-lacZ transcription. PAO607 ex-
pressed about seven-times more b-galactosidase activity than
PAO606. DNA sequence analyses revealed that mexEF-oprN
operon overexpression in PAO573 was not due to changes in
the promoter region.
MexEF-OprN expression in PAO573 is independent of
MexT
Since lacZ fusion and Western blot experiments confirmed
transcriptional and translational expression of MexEF-OprN, we
next probed the status of mexT in the two mutant strains since the
parental strain PAO393 was derived from a PAO1 strain with an
8-bp insertion in mexT. PCR amplification and sequencing of the
mexT gene from PAO1, PAO393 and PAO573 revealed that the 8-
bp insertion was lost from PAO393 (the mutant isolated from
ciprofloxacin-supplemented media) but not from PAO573 (the
mutant strain isolated as a large colony variant on LB agar) (Fig. 4).
This indicates MexT-dependent MexEF-OprN expression in
PA393 but MexT-independent expression of this efflux pump in
PAO573.
Attempts at identification of mexEF-oprN regulatory
proteins other than MexT
Since the mexEF-oprN operon expression was constitutively
expressed in a MexT-independent manner in PAO573 we
hypothesized that additional regulatory protein(s) may be involved
in regulation of its expression. We attempted two experimental
approaches to test this hypothesis, random mutagenesis of
mexEpromoter-lacZ bearing strains and identification of clones in a
P. aeruginosa expression library that either up- or down-regulate b-
galactosidase expression in mexEpromoter-lacZ bearing strains.
Random mutagenesis approaches
In order to identify elements involved in the regulation of
MexEF-OprN pump, our first approach involved random
mutagenesis using the Mariner transposon delivery vector pBT20
[34], of PAO604 (PAO1::mexEpromoter-lacZ) in order to identify
potential repressor protein(s). Since colonies of PAO604 are white
on LB agar plates supplemented with X-gal, we screened for blue
colonies following the transposon mutagenesis as an insertion in a
repressor gene should result in increased expression of the b-
galactosidase gene under the control of mexE promoter. However,
in spite of several attempts, we were unable to find any mutants
that showed up-regulation of b-galactosidase expression.
In an attempt to find potential activator(s), we attempted
random mutagenesis screen in PAO607 (PAO573::mexEpromoter-
lacZ fusion). We assumed that if the expression of mexEF-oprN in
this strain was due to an altered activity of an activator molecule
then disruption of such molecule would result in white colonies on
LB-agar supplemented with X-gal. However, our attempts
repeatedly identified insertions in the lacZ gene only.
Screening of a P. aeruginosa expression library
Since transposon mutagenesis did not identify any regulatory
protein candidates, we decided to search for a potential repressor
Figure 2. Immunodetection of OprN. Western blot analyses was
performed on whole cell lysates of strains PAO1 (wild-type), PAO386
(PAO1 with D(mexAB-oprM) D(mexCD-oprJ) D(mexJK) D(mexXY) DopmH
mexT with 8 bp insertion), PAO393 (ciprofloxacin resistant variant of
PAO386 expressing MexEF-OprN mexT
+), and PAO573 (LB-selected
variant of PAO386 expressing MexEF-OprN mexT with 8 bp insertion)
using anti-OprN antibodies to confirm the expression of OprN
(indicated by the arrow). OprN was only detectable in extracts of
PAO393 and PAO573.
doi:10.1371/journal.pone.0026520.g002
Figure 3. Expression of mexEF-oprN in P. aeruginosa strains as
determined by mexEpromoter-lacZ reporter fusion assays. b-
galactosidase assays were performed on P. aeruginosa strains harboring
single-copy mexEpromoter-lacZ fusions on mini-Tn7 elements integrated
in the chromosome at the attTn7 site. PAO604, PAO1:: mexEpromoter-lacZ;
PAO605, PAO386:: mexEpromoter-lacZ; PAO606, PAO393:: mexEpromoter-
lacZ; and PAO607,PAO573:: mexEpromoter-lacZ. For relevant host strain
genotypes see Fig. 2 legend.
doi:10.1371/journal.pone.0026520.g003
Figure 1. Emergence of large colony variants expressing
mexEF-oprN. P. aeruginosa PAO386 was plated on LB agar and
incubated at room temperature for 5 d, following an initial overnight
incubation at 37uC. Large colony variants emerged at a high frequency
(examples are indicated by red arrows). One such variant (named
PAO573) was isolated and retained for further examination.
doi:10.1371/journal.pone.0026520.g001
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(PAO573::mexEpromoter-lacZ) with a PAO1 plasmid library and
identified four colonies harboring recombinant plasmids that could
repress the expression of a b-galactosidase gene under the control
of the mexE promoter (Fig. 5). Sequencing of the four recombinant
plasmids thus identified – pPS1640, pPS1642, pPS1643 and
pPS1644 - revealed several possible regulatory protein candidates.
Plasmid pPS1640 harbored PA2050 that encodes for a probable
sigma factor. A recent study has speculated on the role of a yet
unidentified sigma-factor in the expression of MexEF-OprN pump
[35]. In order to avoid any inadvertent expression of the MexEF-
OprN system in PAO386, we decided to use PAO327 for the
follow up studies. This strain is a stable D(mexAB-oprM) D(mexCD-
oprJ) D(mexXY) derivative of PAO1 and its mexEF-oprN operon is
uninducible as a result of the 8-bp mexT insertion. We deleted
PA2050 from PAO707 (PAO327:mexEpromoter-lacZ) to obtain
PAO709, and observed a dramatic increase in b-galactosidase
activity which could be repressed by the introduction of the
plasmid-borne PA2050 gene (Fig. 6A). However, the phenotype
observed upon deletion of PA2050 was not reproducible every
time as transfer of the deletion back into PAO707 did not result in
a consistent phenotype, nor did its deletion have any effect on the
expression of MexEF-OprN pump in the wild type strain P.
aeruginosa PAO1. Additionally, we did not find any mutations in
the PA2050 gene in PAO573 (data not shown).
Plasmid pPS1642 was also shown to repress the b-galactosidase
activity in our reporter strain. This plasmid contains a 1,710 bp
insert that includes a partial sequence of the mvaT gene, missing
124 bp of the 59-end. Even though the insert contained only a
partial sequence of the mvaT gene, the product of which has been
implicated in the expression of mexEF-oprN operon [29], we used a
mvaT insertion mutant available from the University of Washing-
ton Genome Center in order to investigate its role in the
expression of MexEF-OprN system in our strain. We inserted the
mini-Tn7T-mexEpromoter-lacZ reported fusion in this strain
(PAO1084), however the strain did not show any increased
promoter activity compared to the derivative (PAO1081) contain-
ing the promoter-less lacZ insertion (data not shown).
The plasmid pPS1643 contains the ORFs PA0486 and PA0487.
PA0486 encodes a protein with homology to serine/threonine
kinases and PA0487 encodes a probable molybdenum transport
regulator. We decided to investigate its role in the expression of the
mexEF-oprN operon. For reasons detailed above, we used again the
PAO327 background and created PAO719 by deleting PA0487
from PAO707 which is an unmarked derivative of PAO327
containing the mexEpromoter-lacZ fusion. This strain not only
exhibited increased b-galactosidase activity (Fig. 6B) but also
elevated MICs for chloramphenicol and trimethoprim (512 mg/
mL and .1024 mg/mL, respectively) when compared to the
PAO719 parental strain which exhibited MICs for chloramphen-
icol and trimethoprim of 2 mg/mL and 32 mg/mL, respectively.
However, introduction of pPS1643 (containing PA0487) gene did
not cause a reduction in b-galactosidase activity (Fig. 6B). We
created a number of mutants of PAO327 containing gene
deletions of PA0487. However, as in the case of PA2050 discussed
above, the phenotype observed upon deletion of PA0487 was not
reproducible every time as the transfer of the deletion in PAO707
did not result in a consistent phenotype, nor did the deletion have
any effect on the expression of MexEF-OprN pump in the wild-
type PAO1. Additionally we did not find any mutations in the
PA0487 gene in PAO573 (data not shown).
Lastly, pPS1644 contains an approximately 4.5 Kb insert that
includes the upstream region of mexEF-opN operon consisting of
the mexT and mexS genes along with PA2489, a gene that encodes
Figure 4. Confirmation of the presence of 8-bp insertion in the
mexT gene. The mexT gene was PCR amplified from genomic DNA
templates of PAO1, PAO386, PAO393 and PAO573, and sequenced to
confirm the presence or absence of the 8-bp insertion (shown in red)
after nucleotide 231. For relevant strain genotypes see Fig. 2 legend.
doi:10.1371/journal.pone.0026520.g004
Figure 5. Screening of P. aeruginosa PAO1 library clones for repression of mexEF-oprN operon transcription. b-galactosidase assays were
performed using the indicated P. aeruginosa strains with or without plasmids containing various PA genes. PAO604 is PAO1:: mexEpromoter-lacZ
(negative expression control) and PAO607 is PAO573:: mexEpromoter-lacZ (positive expression control). Plasmids carry the following genes: pPS1640
(PA2050 [probable sigma factor]); pPS1642 (partial sequence of PA4315 [mvaT]); pPS1643 (PA0486-PA0487 [molybdenum transport regulator]); and
pPS1644 (PA2489 [AraC-type regulator]-PA2490 [hypothetical protein]-PA2491 [mexS]-PA2492 [mexT]).
doi:10.1371/journal.pone.0026520.g005
P. aeruginosa MexEF-OprN Expression
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a hypothetical protein. Since MexS was previously shown to be
involved in the regulation of mexEF-oprN operon expression [27],
we sequenced the mexS genes from PAO386 and PAO573.
Sequence comparisons did not reveal any mutations in the mexS
gene of PAO573 (data not shown). Also, since MexS activity is
MexT-dependent and since mexT gene product in PAO573
remains inactive as a result of the 8-bp insertion, we do not
believe that MexS plays a role in the repression of mexEpromoter-
lacZ encoded b-galactosidase activity by pPS1644. In order to
Figure 6. Effect of PA2050, PA0487, and PA2489 on the expression of mexEF-oprN operon. A. Deletion of PA2050 in PAO707. PAO709
contains a gene deletion of PA2050 introduced into PAO707 which is PAO1 with D(mexAB-oprM) D(mexCD-oprJ) D(mexXY) and chromosomally-
integrated mexEpromoter-lacZ; pPS1640 contains the gene PA2050 cloned in pUCP20. B. Deletion of PA0487 in PAO707. PAO719 contains a gene
deletion of PA0487 in PAO707; pPS1643 contains the gene PA0487 in pUCP20. C. Expression of PA2489. pPS1648 containing the PA2489 gene was
electroporated into PAO607 (PAO573::mexEpromoter-lacZ); pUCP20 was used as the vector control. PAO604 is the PAO1:: mexEpromoter-lacZ negative
control and PAO607 is the PAO573::mexEpromoter-lacZ positive control.
doi:10.1371/journal.pone.0026520.g006
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transcriptional regulator), we deleted a 2,291 fragment that
contained mexT and 180 bp of the 39-end of the PA2490 gene
thus effectively removing all three (mexT, mexS, and PA2490) genes
from pPS1644 but leaving PA2489 intact. However, transforma-
tion of the resulting pPS1648 into PAO607 did not result in any
decrease in b-galactosidase activity (Fig. 6C).
Discussion
In this study, we attempted to identify factors that control the
expression of MexEF-OprN pump in the absence of antibiotic
substrates. To avoid interference by other efflux systems we
employed a P. aeruginosa strain that is lacking four different RND
pumps (MexAB-OprM, MexCD-OprJ, MexJK, and MexXY). In
addition,the strainalsolacks theouter membraneproteinOpmH,a
TolC homolog, that has been shown to function with at least two
different RND pumps in P. aeruginosa, MexJK [36] and TriABC
[23]. We were readily able to isolate MexEF-OprN overexpressing
mutants of this strain in the presence of media supplemented with
ciprofloxacin. These mutants consistently showed a loss of the 8-bp
insertion in the mexT gene resulting in expression of active MexT
which induces theexpression ofthe MexEF-OprN pump.However,
in absence of any antibiotics in the media, colonies of PAO386
appear very small and have a pin-point morphology, some of which
upon longer incubation give rise to a large colony variant. These
large colony variants showed an increased expression of MexEF-
OprN pump as confirmed in the representative strain PAO573 by
increased MICs to MexEF-OprN substrates, detection of OprN by
immunoblotting with anti-OprN antibodies (Fig. 2), b-galactosidase
assays with strains expressing mexEpromoter-lacZ transcriptional
fusions (Fig. 3), and also qRT-PCR using mexEF-oprN operon
specific primers (data not shown). Since the 8-bp insertion was still
present in the mexT gene of PAO573, the overexpression of the
MexEF-OprN operonwas independent of MexT protein suggesting
a role of other regulator(s) in the expression of this pump.
A search for such regulator(s) using a transposon mutagenesis
approach was unsuccessful, but screening of a PAO1 expression
library for clones capable of repressing b-galactosidase expression
in a PAO573::mexEpromoter-lacZ host revealed several candidates.
We identified and sequenced four different recombinant plasmids
from the screening of the PAO1 library, namely pPS1640
(containing the ORF PA2050), pPS1642 (containing the partial
sequence of PA4315), pPS1643 (containing the ORFs PA0486-
PA0487), and pPS1644 (containing PA2489-mexS-mexT), that were
found to repress the expression of the reporter b-galactosidase
gene in the host strain (Fig. 5). PA0487 encodes a probable
molybdenum transport regulator, PA2050 encodes a probable
sigma factor, while PA4315 encodes for the transcriptional
regulator MvaT. The insert in pPS1644 contains a gene
(PA2489) that encodes an AraC family transcriptional regulator,
a gene (PA2490) that encodes for a hypothetical protein, and also
the mexS and mexT genes. While these genes repress mexE promoter
activity in the PAO573 background, deletion and re-transforma-
tion analyses gave inconsistent results, especially PA0487 and
PA2050, and did not yield the same phenotypes, i.e. mexEF-oprN
expression, when the respective genes were mutated in PAO1.
Furthermore, when PCR-amplified from PAO573 the genes
contained on and presumably expressed by the respective plasmids
did not contain any mutations.
One of the reasons for inconsistent observations for deletion
phenotypes for PA0487 and PA2050 could be the unstable nature
of our mutants. One notable point is that the phenotype that we
observed in PAO573 results from the deletion of OpmH, which
may indicate that the possible physiological stress on this strain
could be a cumulative effect of hampered activity of other yet
uncharacterized pumps that may require OpmH for function, and
the mexEF-oprN over-expressing phenotype is likely to be a result of
accumulation of metabolic by-products or secondary metabolites.
Also, our study is difficult to repeat in the wild-type strain since the
activity of other pumps (that were deleted in PAO386) would most
likely prevent the over-expression of MexEF-OprN pump.
In conclusion, our study shows that the expression of MexEF-
OprN pump can be derepressed in absence of antibiotic stress as
shown by some of the previous studies [32,33]. We also provide
further evidence for regulation of the expression of mexEF-oprN
pump being under control of a very complex regulatory network
and that additional studies are required to understand the
underlying mechanisms. In support of this notion, a recent study
postulated transcriptional regulation of the mexEF-oprN multidrug
efflux operon by an unidentified repressor [34] but it remains pure
speculation whether inactivation of this repressor might be the root
cause for the observed mexEF-oprN operon over-expression in
PAO573. In this context, however, it is interesting to note that just
as deletion of the putative repressor-binding site caused high-level
mexEF-oprN expression [34], the unknown mutation(s) present in
PAO573 also caused a level of MexT-independent mexEF-oprN
expression that was significantly higher than that observed in
PAO393 where mexEF-oprN expression was MexT-dependent
(Fig. 3). The most striking discovery of the present study is that
antibiotic and metabolic stressors lead to MexEF-OprN over-
expression by independent mechanism(s). Antibiotic stress caused
mexEF-oprN over-expression via a MexT dependent mechanism
whereas metabolic stress caused expression of this operon via a
MexT-independent mechanism. While the nature of the metabolic
signal(s) causing MexEF-OprN expression remain unknown, our
results provide further evidence that RND efflux pumps not only
extrude antimicrobials but rather serve other important metabolic
functions.
Materials and Methods
Bacterial strains, plasmids and growth conditions
P. aeruginosa strains used in this study are listed in Table 1. E. coli
DH5a (Invitrogen, Carlsbad, CA) was used for the gene cloning
experiments. LB medium (EM Sciences, Gibbstown, NJ) was used
for the growth of E. coli and P. aeruginosa strains. When required,
the growth medium was supplemented with the following
antibiotics: ampicillin (Ap) (Sigma, St. Louis, MO) (100 mg/mL,
E. coli), carbenicillin (Cb) (Gemini Bioproducts, Sacramento, CA)
(200 mg/mL, P. aeruginosa), and gentamicin (Gm) (Sigma) (30 mg/
mL, P. aeruginosa).
MexEF-OprN overexpressing strains were isolated by streaking
PAO386 on LB agar or LB agar supplemented with 0.05 mg/mL
of ciprofloxacin (Cp; Sigma). A list of plasmids used in this study is
provided in Table S1.
Antibiotic susceptibility assays
Antibiotic susceptibility testing was performed for chloram-
phenicol and trimethoprim using the two-fold microdilution
method as specified by the Clinical Laboratory Standards Institute
[37]. Both antibiotics were purchased from Sigma.
Polymerase chain Reactions, DNA manipulations, and
genetic techniques
PCR reactions were performed using either Taq DNA
polymerase (New England Biolabs, Beverly, MA) or HiFi high-
fidelity Taq polymerase (Invitrogen, Carlsbad, CA).
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the DNA was performed using kits available from Qiagen (Qiagen,
Valencia, CA). Transfer of DNA into P. aeruginosa strains was
achieved either by using tri-parental mating [38] or by the 10-
minute rapid electroporation [39] methods described previously.
Construction of the reporter fusion using the promoter region of
the mexEF-oprN operon (mexEpromoter) and the promoter-less E. coli
lacZ gene was accomplished as follows. The promoter region of the
mexEF-oprN operon was amplified on a 683-bp fragment from
PAO1 genomic DNA using Taq polymerase, primers 557 (59-
GCCAGCTGCAGCTCGACGACTATTGCG; a PstI site is
underlined) and 558 (59-TTTCCGGAAGCTTGCCGCAGG-
CGCTCA; a HindIII site is underlined), and cloned into the TA
cloning vector pCR2.1 (Invitrogen, Carlsbad, CA) to obtain
pPS1496. Next, a 420-bp DNA fragment containing the 36
carboxy-terminal mexT codons, the 29 amino-terminal mexE
codons and the 230-bp mexT-mexE intergenic region with the
mexE promoter was obtained after digestion of pPS1496 DNA with
HindIII and SmaI. The SmaI-HindIII fragment was gel-purified,
and cloned into the reporter plasmid pPS1453 (pUC18-mini-
Tn7T-Gm-lacZ) [40] digested with the same enzymes to derive
pPS1519. Assembly of the mexEpromoter-lacZ fusion construct in a
mini-Tn7 vector allows the insertion of the reporter fusion in single
copy in the P. aeruginosa chromosome, which was achieved using
the helper plasmid pTNS2 [40] and a previously published
protocol [40]. Confirmation of the insertion and the subsequent
removal of the Gm
r-cassette was performed by protocols described
previously [40].
Creation of unmarked gene deletions in P. aeruginosa was
performed using previously described methods [41].
Immunodetection of OprN
Western blot detection of the OprN protein (the outer
membrane component of the MexEF-OprN pump) was performed
using an anti-OprN polyclonal antiserum. One mL of bacterial
cells grown in LB broth to a density of A600 ,1.0 were harvested
and normalized using 26sample buffer (0.0025 w/v bromphenol
blue, 20% v/v glycerol, 6% v/v b-mercaptoethanol, 2.5% w/v
SDS in Tris Buffer). Normalization was carried out as follows,
A60060.08=mL2 6sample buffer. The cell suspension was boiled
for 5 minutes and an equal volume of each sample (3–5 mL) was
loaded on a 10% SDS-polyacrylamide gel. Immunodetection of
the OprN protein was carried out using previously described
protocols [42].
b-galactosidase assays
Reporter strains containing the mexEpromoter-lacZ fusion inserted
in the genome were constructed as described above for PAO1,
PAO386, PAO393, and PAO573 to derive PAO604, PAO605,
PAO606, and PAO607, respectively.
b-galactosidase assays were performed using a previously
described method [43]. Briefly, overnight cultures of bacterial
strains grown in LB-broth at 37uC were subcultured in fresh LB
using a 1:200 inoculum and cultures were grown until they
reached an optical density of approximately one at 600 nm
(A600=1.0), at which point, one mL aliquots were removed and
cells harvested at 13,000 rpm in a microcentrifuge. Cell pellets
were resuspended in 0.1 M phosphate buffer (pH 7.0). Permea-
bilization of cells was achieved by addition of SDS/chloroform.
Assays of b-galactosidase activity and activity unit calculations
were performed as described previously [44].
Construction of P. aeruginosa library
A P. aeruginosa library was constructed by partially digesting
genomic DNA from the wild-type PAO1 with EcoRI and
EcoRI+BamHI and purifying the DNA fragments ranging from
approximately 1.5 Kb to 4 Kb from an agarose gel. The DNA
fragments were dephosphorylated using alkaline phosphatase
(New England Biolabs) following the manufacturer’s instructions
and then ligated into the broad-host range cloning and expression
vector pUCP20 [45] digested with EcoRI and EcoRI+BamHI,
respectively. The ligation mixtures were transformed into E. coli
DH5a cells and plated on LB agar supplemented with ampicillin
(100 mg/mL) and X-gal (5-bromo-4-chloro-3-indolyl-b-D-galacto-
pyranoside; 40 mg/mL) (Gold Biotechnology, St. Louis, MO).
Following an overnight incubation at 37uC, 825 white colonies
were selected and patched on fresh LB agar plates supplemented
with ampicillin (100 mg/mL) and X-gal (40 mg/mL). The patches
were washed off using saline and inoculated into LB broth
supplemented with ampicillin, plasmids were extracted following
an overnight incubation at 37uC with shaking, and electroporated
into PAO607 (the derivative of PAO573 containing the chromo-
somally-integrated mini-Tn7T-mexEpromoter-lacZ fusion). Cells
were plated on LB agar supplemented with Cb (200 mg/mL)
and X-gal (40 mg/mL). Following an overnight incubation at
37uC, four white to light blue colonies were observed and selected
for further analysis. Plasmids were extracted from these four P.
aeruginosa PAO607 transformants and sequenced at Colorado State
University’s Proteomics and Metabolomics Facility.
Supporting Information
Table S1 List of plasmids used in this study.
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